Behavioral Intervention
Integrated Collaborative Care for Youth Mental Health and Addiction
This trial tests a new way of providing mental health and addiction services for young people aged 14-18. The Integrated Collaborative Care Team (ICCT) model involves a team of healthcare providers working together to offer fast and personalized care. The goal is to improve mental health outcomes, reduce waiting times, and be more cost-effective compared to usual treatments.
Behavioral Intervention
Tai Chi for Insomnia in Breast Cancer Survivors
This trial will examine the efficacy of TTC on sleep impairments in women with breast cancer. #BreastCancer is common in women; TTC may improve sleep, fatigue & inflammation, & help long-term survival.
Behavioral Intervention
Mindfulness + Pain Management Visits for Chronic Pain
"This trial aims to see if using Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits can help reduce chronic pain, improve quality of life, and lessen the negative effects
Popular Filters
Trials for Schizophrenia Patients
Monoclonal Antibodies
Ocrelizumab for Psychosis
This trial is investigating whether some people diagnosed with schizophrenia or bipolar disorder may actually have a brain disease caused by auto-antibodies. These auto-antibodies attack brain receptors, leading to symptoms
Behavioural Intervention
Smoking Cessation App for Mental Health Disorders
This trial will test a new smartphone app called Quit on the Go, designed to help people with serious mental illness quit smoking. The study will compare this app to traditional methods, with both groups also using nicotine patches and gum. The goal is to see if the app helps more people quit smoking and if it is cost-effective.
Behavioral Intervention
Cognitive Behavioral Therapy for Serious Mental Illness-related Chronic Pain
This trial is testing whether a therapy called CBT-CP, which is used to help manage chronic pain, is feasible and acceptable to Veterans with SMI, and if it is worth examining in a larger clinical trial.
Behavioral Intervention
Multi-component Intervention for Diabetes in Adults with Serious Mental Illness for Lifestyle Risk Reduction
Persons with schizophrenia and other serious mental illnesses have a high risk for type 2 diabetes and an increased risk of premature mortality compared to the general population. The goals of the proposed study are to implement a multimodal lifestyle intervention to reduce that risk in these individuals living in residential care facilities, a common housing modality for people with serious mental illnesses. If successful, this intervention will lead to reduction in excess medical comorbidity and mortality in persons with serious mental illnesses.
Trials for Schizoaffective Disorder Patients
Monoclonal Antibodies
Ocrelizumab for Psychosis
This trial is investigating whether some people diagnosed with schizophrenia or bipolar disorder may actually have a brain disease caused by auto-antibodies. These auto-antibodies attack brain receptors, leading to symptoms
Behavioural Intervention
Smoking Cessation App for Mental Health Disorders
This trial will test a new smartphone app called Quit on the Go, designed to help people with serious mental illness quit smoking. The study will compare this app to traditional methods, with both groups also using nicotine patches and gum. The goal is to see if the app helps more people quit smoking and if it is cost-effective.
Behavioral Intervention
Cognitive Behavioral Therapy for Serious Mental Illness-related Chronic Pain
This trial is testing whether a therapy called CBT-CP, which is used to help manage chronic pain, is feasible and acceptable to Veterans with SMI, and if it is worth examining in a larger clinical trial.
Behavioral Intervention
Multi-component Intervention for Diabetes in Adults with Serious Mental Illness for Lifestyle Risk Reduction
Persons with schizophrenia and other serious mental illnesses have a high risk for type 2 diabetes and an increased risk of premature mortality compared to the general population. The goals of the proposed study are to implement a multimodal lifestyle intervention to reduce that risk in these individuals living in residential care facilities, a common housing modality for people with serious mental illnesses. If successful, this intervention will lead to reduction in excess medical comorbidity and mortality in persons with serious mental illnesses.
Trials With No Placebo
Behavioral Intervention
Mastering the World of Work for Mental Illness
This trial is testing a new intervention called "Mastering the World of Work" to see if it can help improve employment outcomes for people with psychiatric disabilities who have trouble with things like forming a sense of self and others, and responding to challenges in life. The trial will be conducted with 60 people who are already receiving supported employment services, and will involve assessments at different points over 18 months.
Health Services
Mental Health Care Bundle for Pediatric Psychiatric Emergency
This trial will compare an acute mental health care bundle to standard care in order to determine if it improves wellbeing in children and youth who seek emergency department care for mental health and substance use concerns.
Alpha-2 Adrenergic Agonist
Dexmedetomidine for Postoperative Cognitive Dysfunction
This trial is testing whether the drug Dexmedetomidine can prevent postoperative cognitive dysfunction (POCD), which is when patients have trouble thinking and remembering after surgery.
View More Related Trials
Frequently Asked Questions
Introduction to mental illness
What are the top hospitals conducting mental illness research?
In the realm of mental health research, several hospitals have been making significant strides in understanding and treating various mental illnesses. One such institution is the University of Michigan in Ann Arbor, where cutting-edge advancements are being made through three ongoing clinical trials focused on mental illness. With a total of nine trials conducted to date, the university's commitment to addressing these conditions became evident with their first recorded trial back in 2011. Similarly dedicated to this cause is Edward Hines Jr. VA Hospital located in Hines, Illinois. This facility has three active mental illness trials underway and has embarked upon four such studies since its inaugural trial in 2016.
On the west coast lies VA San Diego Healthcare System, situated within sunny San Diego, California – also deeply invested in improving our understanding and treatment options for mental illnesses like never before.Their current involvement encompasses researching through three ongoing clinical tests which further adds up towards seven investigations that they previously accomplished since recording their very first trial as early as2008.Meanwhile Washington University School of Medicine based out at Saint Louis showcases their equal contribution; offering a combination summing upto six steps towards establishing better ways tackling psychiatric disorders -all consisting underlying comprehensive examinations exploring areas not limited but including bipolar disorder or schizophrenia . Their initiation on investigating these cases dated back until 2010
Additionally adding itself to this list is Butler Hospital located within Providence,Rhode island ,where they've stepped ahead venturing amongst two intellectual malady related experimental tests currently while they hold proud representation contributing by accomplishment of additional previous three exploratory measures dating from recent history records tracing it just around half a decade ago till2015.These esteemed institutions serve as beacons of hope for those affected by mental illness.With each trial conducted we inch closer towards unraveling the complexities surrounding these conditions and unlocking innovative approaches to enhance lives worldwide
Which are the best cities for mental illness clinical trials?
When it comes to mental illness clinical trials, several cities are at the forefront of research and innovation. Toronto, Ontario leads with 13 active trials exploring interventions like Integrated Collaborative Care Team (ICCT) and Addressing Depression and Positive Parenting Techniques (ADAPT) Program. Baltimore, Maryland follows closely behind with 10 ongoing studies focusing on interventions such as CBI-CC with peer navigation and Nicotine Patch for smoking cessation. New york, New York has 8 active trials investigating treatments like Adapted IPS and E-cigarettes (EC). Additionally, Saint Louis in Missouri and Boston in Massachusetts each have 6 active trials studying various approaches to mental health care. These cities offer individuals struggling with mental illness opportunities to participate in cutting-edge clinical trials that can lead to improved treatment options and better outcomes.
Which are the top treatments for mental illness being explored in clinical trials?
The world of mental health is continuously advancing, with clinical trials exploring various treatment options for mental illness. One notable contender in these trials is intervention, currently being tested in two active studies. Since its first listing in 2017, it has shown promise as a potential game-changer in the field of mental health. As researchers delve deeper into understanding and addressing mental illness, interventions like this hold great potential to improve the lives of those affected by these conditions.
What are the most recent clinical trials for mental illness?
Exciting advancements are being made in the field of mental health through recent clinical trials. The trials include active iTBS, which explores a potential treatment for mental illness in its early stages. Another trial investigates the effectiveness of dasatinib + quercetin as a therapeutic option for those with mental illness. Lumateperone is also being studied to assess its benefits in managing various forms of mental illness. Additionally, Donanemab Dose Level 4 and Experimental: 1.0 mg/kg XPro1595 are both undergoing evaluation to determine their efficacy as treatments for individuals with mental illness. These groundbreaking studies show promise in improving the quality of life for those affected by mental health disorders.
(Note: I have chosen not to exclude any relevant information from this answer as it already provides concise details about each clinical trial mentioned.)
What mental illness clinical trials were recently completed?
Recently, several notable clinical trials investigating potential treatments for mental illnesses have reached completion. One such trial, involving LY03010; paliperidone palmitate and sponsored by Luye Pharma Group Ltd., was concluded in January 2021. Additionally, the University of California, San Diego completed their trial exploring Varenicline in August 2019 as a possible treatment option. In another significant study supported by NYU Langone Health, Levetiracetam was investigated for its therapeutic potential and wrapped up in August 2017. These advancements shed light on ongoing efforts to develop effective interventions for individuals struggling with mental illness and offer hope for improved care in the future.